---
schema_version: "secwatch.filing_event.v1"
accession: "0001288847-24-000085"
form_type: "8-K"
ticker: "FIVN"
cik: "0001288847"
company_name: "Five9, Inc."
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:39:35.832073+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Five9 appoints Maria Walker to Board of Directors effective May 21, 2024

## Summary
- Walker appointed as Class I Director; term expires at 2027 annual meeting.
- She will serve on the Audit Committee.
- Initial RSU grants: $400,000 vesting over 3 years and $200,000 vesting in 1 year.
- Walker is former CFO of Patient Square Capital (retired Dec 2023) and ex-KPMG audit partner.
- No related-party transactions or arrangements in connection with appointment.

## SEC filing metadata
- accession: 0001288847-24-000085
- form_type: 8-K
- ticker: FIVN
- cik: 0001288847
- company_name: Five9, Inc.
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1288847/000128884724000085/0001288847-24-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1288847/000128884724000085/fivn-20240521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001288847-24-000085
- JSON: https://secwatch.observer/filing/0001288847-24-000085.json
- Plain text: https://secwatch.observer/filing/0001288847-24-000085.txt

## Key facts
- Executive change
  Maria Walker was appointed as Class I Director at Five9, Inc..
  - Action: appointed
  - Role: Class I Director
  source text: On May 21, 2024, the Board of Directors (the “Board”) of Five9, Inc. (the “Company”) appointed Ms. Maria Walker to serve on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1288847/000128884724000085/0001288847-24-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.